level ≥4.0 ng/ml is predictive of prostate cancer, and necessitates a biopsy. But there is a dearth of prospective data on the predictive value of PSA levels below this threshold. To analyse the ...

The following is a summary of “Optimal PSA density threshold for prostate biopsy in benign prostatic obstruction patients ...

—Physicians surveyed for a new study said that reports generated by artificial intelligence (AI) were, with a few exceptions, accurate and complete. They could also be modified faster than ...

All repeat biopsies used a transrectal ultrasound-guided 12-core protocol, in which six biopsy cores were obtained from the periphery of the prostate (directed bilaterally at the base, mid-zone ...

Bill Faulkner had long approached prostate cancer testing with skepticism. For almost a decade, the 73-year-old had avoided ...

It's common for healthcare professionals to order biopsies for patients whom they suspect may have prostate cancer. A biopsy doesn't just rule out prostate cancer or show its presence, though.

After surgical removal of the prostate to treat prostate cancer, clinicians monitor prostate specific antigen (PSA) levels. Persistently elevated PSA levels indicate residual cancer and are linked to ...

Prediction of the probability of recurrence after surgery with the use of the available information before the surgery (prostate-specific antigen [PSA] level, Gleason score of the biopsy specimen ...

One hundred twenty-seven patients underwent prostate biopsy, with 94 prostate cancers diagnosed (74.0% of biopsies); 86.2% were cancers with clinically significant disease (grade group 2 or higher).